From Puma Biotechnology's results release of 5 ноября 2026 г.; its quarterly report has since been filed.

• Revenue

  Actual

  55,1M $

  +1,1 % y/y ↑
  -2,6 % q/q ↓

  Guided

  57,5M $

  midpoint

  ↓ Below guide-4,3 %

• EPS, GAAP

  Actual

  0,11 $

  -35 % y/y ↓
  -31 % q/q ↓

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  5,3M $

  -45 % y/y ↓
  -30 % q/q ↓

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.